Login to Your Account

Autolus advances with $57M B round as Itin takes the helm as CEO

By Cormac Sheridan
Staff Writer

Thursday, March 3, 2016

DUBLIN – Autolus Ltd. bagged £40 million (US$56.6 million) in a series B round to take forward its next-generation chimeric antigen receptor (CAR) T-cell technology, a little more than a year after it took in £30 million in series A funding.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription